Outcomes From Cytotoxic Chemotherapy Following Progression on Immunotherapy in Metastatic Melanoma: An Institutional Case-Series

INTRODUCTION: The role of chemotherapy in the management of advanced melanoma is limited due to low response rates and short survival. Improved outcomes to chemotherapy administered after immunotherapy for metastatic melanoma and other solid tumors have been reported. We studied the outcomes of subj...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaughan, Elizabeth M., Horton, Bethany J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096114/
https://www.ncbi.nlm.nih.gov/pubmed/35574303
http://dx.doi.org/10.3389/fonc.2022.855782

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096114/
https://www.ncbi.nlm.nih.gov/pubmed/35574303
http://dx.doi.org/10.3389/fonc.2022.855782

Ejemplares similares